通过ADAM17和BACE1,OLED光疗对认知功能和β-粉样蛋白减少的颜色依赖
Byeongju Noh1, Hyun-Ju Lee2, Jiyun Lee3,4
1School of Electrical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
ACS biomaterials science & engineering
|October 25, 2025
概括
在阿尔茨海默病 (AD) 鼠标模型中,红色和白色光刺激改善了认知功能,并减少了粉样β (Aβ) 病理. 通过调节特定的酶活动,红光独特地增强了记忆力并减少了Aβ斑块.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样β (Aβ) 病理.
- 之前的研究表明,40 Hz视觉刺激在AD模型中降低了Aβ水平.
- 不同颜色的光线对阿尔茨海默氏症病理的明显影响仍然不清楚.
研究的目的:
- 为了研究基于优化有机发光二极管 (OLED) 的视觉刺激对5xFAD小鼠认知功能和Aβ病理的颜色依赖性影响.
- 在AD模型中探索光诱导治疗效果的潜在机制.
主要方法:
- 开发了一个统一的OLED视觉刺激平台.
- 用不同的光色 (白色,红色,绿色,蓝色) 对5xFAD小鼠进行了急性和慢性视觉刺激.
- 评估认知功能,Aβ斑块积累,ADAM17和BACE-1活动,IL-1β水平和c-fos表达.
主要成果:
- 在年轻的5xFAD小鼠中,急性白色或红色光改善了认知能力,减少了海马Aβ斑块,并降低了IL-1β的调节.
- 慢性白色和红色光增强了老5xFAD小鼠的识别记忆.
- 红光通过上调ADAM17和抑制BACE-1而独特地减少了Aβ斑块,而不会影响神经炎症.
- 敏的白光和红光都增强了c-fos表达,表明神经激活.
结论:
- 颜色依赖的视觉刺激,特别是红光,显示出作为阿尔茨海默病的电疗法战略的希望.
- 红光提供了一种独特的组合,可以增强记忆力,减少Aβ和抗炎作用.
- 通过红光调节ADAM17和BACE-1活动是减少Aβ斑块的关键机制.
相关概念视频
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


